Amgen Inc. beat Wall Street expectations for earnings and revenue in its first fiscal quarter.
Amgen Inc. said a new study showed its drug Aimovig is an effective preventive treatment migraine patients who have tried other treatments that either didn’t work or had intolerable side effects, the company announced Tuesday.
Skin treatments provide youthful edge for older job-seekers and executives.
Shares of Simulations Plus Inc. rose more than 6 percent Tuesday after the company reported results for its second fiscal quarter.
Amgen Inc. will build a new manufacturing plant at the site of its existing facilities in West Greenwich, R.I., the pharma company announced Tuesday.
Shares of MannKind Corp. fell nearly 25 percent Friday, after the company announced a $28 million stock offering.
Amgen Inc.’s bone drug Xgeva has been approved by the European Commission for the prevention of skeletal complications in patients with multiple myeloma, a bone marrow cancer.
Apollo Medical Holdings Inc. has announced its fiscal year results, but the financial numbers only reflect 23 days’ of the company’s performance.
Amgen Inc.’s leukemia drug Blincyto has become the first drug to be approved by the Food and Drug Administration for use in a subgroup of leukemia patients who are at a high risk of relapse following initial treatment.
Sienna Biopharmaceuticals Inc., an aesthetic dermatological product company based in Westlake Village, has hired Allergan Inc. senior marketing manager Caroline Van Hove as its chief commercial officer.
Second Sight Medical Products Inc. has named John Blake as its new chief financial officer.
Sienna Biopharmaceuticals Inc. has hired John Smither as chief financial officer, returning him to a position he previously held.
Fifteen thousand workers in California – including more than 700 in Northridge – have ratified a new contract with Dignity Health, according to Service Employees International Union – United Healthcare Workers West.
Sylmar medical device firm Second Sight Medical Products Inc. has appointed Gregg Williams, the company’s largest shareholder, as chairman of its board of directors.
SnapMD has announced a partnership with the National Center for Telehealth at the University of Mississippi Medical Center for use of the company’s proprietary software.